Vinorelbine tartrate and Blood uric acid increased - a phase IV clinical study of FDA data

Summary:

Blood uric acid increased is reported only by a few people who take Vinorelbine Tartrate.

The phase IV clinical study analyzes which people take Vinorelbine tartrate and have Blood uric acid increased. It is created by eHealthMe based on reports of 2,402 people who have side effects while taking Vinorelbine tartrate from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

2,402 people reported to have side effects when taking Vinorelbine tartrate.
Among them, 4 people (0.17%) have Blood uric acid increased.


What is Vinorelbine tartrate?

Vinorelbine tartrate has active ingredients of vinorelbine tartrate. eHealthMe is studying from 2,409 Vinorelbine tartrate users for its effectiveness, alternative drugs and more.

What is Blood uric acid increased?

Blood uric acid increased is found to be associated with 1,346 drugs and 861 conditions by eHealthMe.

Number of Vinorelbine tartrate and Blood uric acid increased reports submitted per year:

Could Vinorelbine tartrate cause Blood uric acid increased?

Gender of people who have Blood uric acid increased when taking Vinorelbine tartrate *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Blood uric acid increased when taking Vinorelbine tartrate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 100 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Vinorelbine tartrate *:

  1. Xeloda: 1 person, 25.00%
  2. Vagifem: 1 person, 25.00%
  3. Taxotere: 1 person, 25.00%
  4. Taxol: 1 person, 25.00%
  5. Perjeta: 1 person, 25.00%
  6. Kadcyla: 1 person, 25.00%
  7. Fragmin: 1 person, 25.00%
  8. Decadron: 1 person, 25.00%

Common side effects people have besides Blood uric acid increased *:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 50.00%
  2. Weight Increased: 1 person, 25.00%
  3. Aspartate Aminotransferase Increased: 1 person, 25.00%
  4. Blood Creatinine Increased: 1 person, 25.00%
  5. Blood Glucose Decreased: 1 person, 25.00%
  6. Blood Lactate Dehydrogenase Increased: 1 person, 25.00%
  7. Blood Phosphorus Increased: 1 person, 25.00%
  8. Carbon Dioxide Increased: 1 person, 25.00%
  9. Cough: 1 person, 25.00%
  10. Diplopia (double vision): 1 person, 25.00%

Common conditions people have *:

  1. Breast Cancer: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vinorelbine tartrate and have Blood uric acid increased?

Check whether Blood uric acid increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Blood uric acid increased and when was it recovered:

Expand to all the drugs that have ingredients of vinorelbine tartrate:

Alternative drugs to, pros and cons of Vinorelbine tartrate:

Common Vinorelbine tartrate side effects:

Browse all side effects of Vinorelbine tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Blood uric acid increased treatments and more:

COVID vaccines that are related to Blood uric acid increased:

Common drugs associated with Blood uric acid increased:

All the drugs that are associated with Blood uric acid increased:

Common conditions associated with Blood uric acid increased:

All the conditions that are associated with Blood uric acid increased:

How the study uses the data?

The study uses data from the FDA. It is based on vinorelbine tartrate (the active ingredients of Vinorelbine tartrate) and Vinorelbine tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: